| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |